California’s Stem Cell Agency invested $25 million for discovery and preclinical research, patient support program
On Mar. 29, 2024, the California Institute for Regenerative Medicine (CIRM) announced awards that support 11 projects in…
The Priestley Medal was awarded to Carolyn R. Bertozzi
On Mar. 28, 2024, the American Chemical Society awarded The Priestley Medal to Carolyn R. Bertozzi “to recognize…
Genetic secrets from 4,000-year-old teeth illuminate the impact of changing human diets over the centuries
On Mar. 27, 2024, researchers from Trinity College Dublin announced they had recovered remarkably preserved microbiomes from two…
FDA issued EUA for Pemgarda (pemivibart) for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents
On Mar. 22, 2024, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for Pemgarda…
In a first, genetically edited pig kidney was transplanted into a human
On Mar. 21, 2024, Harvard Medical School physician-scientists at Massachusetts General Hospital announced they had successfully transplanted a…
Eledon Pharma announced use of tegoprubart in first-ever transplant of genetically modified kidney from a pig to a human
On Mar. 21, 2024, Eledon Pharmaceuticals announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a…
FDA approved nonsteroidal treatment for Duchenne Muscular Dystrophy
On Mar. 21, 2024, the U.S. Food and Drug Administration (FDA) approved Italfarmaco’s Duvyzat (givinostat) oral medication for…
Biotechnology | Disease | Environmental | EPA | Therapeutics
U.S. Environmental Protection Agency finalized ban on ongoing uses of asbestos to protect people from cancer
On Mar. 18, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule to prohibit ongoing uses…
Biotechnology | Disease | FDA | Therapeutics
FDA approved first gene therapy for children with metachromatic leukodystrophy
On Mar. 18, 2024, the U.S. Food and Drug Administration (FDA) approved Orchard Therapeutics’ Lenmeldy (atidarsagene autotemcel), the…
Microsoft and Fred Hutch Working together to end cancer faster
On Mar. 14, 2024, Microsoft and the Fred Hutch announced a collaboration to end cancer faster, applying machine…
Biotechnology | Disease | FDA | Therapeutics
FDA approved first treatment for patients with liver scarring due to fatty liver disease
On Mar. 14, 2024, the U.S. Food and Drug Administration (FDA) approved Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the…
COVID reduced global life expectancy by 1.6 years
On Mar. 14, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
NIH researchers identified brain connections associated with ADHD in youth
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
Biotechnology | FDA | Therapeutics | Vaccine
Wegovy received FDA approval for cardiovascular risk reduction in adults with known heart disease or obesity
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
Hugel Received FDA Approval in the U.S. of Letybo (letibotulinumtoxinA-wlbg) for Injection for Treatment of Glabellar Lines
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
New antibodies target ‘Dark Side’ of influenza virus protein
On Mar. 1, 2024, researchers at the National Institutes of Health (NIH) announced they had identified antibodies targeting…
CDC | COVID-19 | Therapeutics | Vaccine
CDC Advisory Committee recommended older adults able to receive additional dose of updated COVID-19 vaccine
On Feb. 28, 2024, the CDC Advisory Committee on Immunization Practices’ (ACIP) announced a recommendation for adults ages…
California’s Stem Cell Agency awarded $56 million for clinical research, $21.3 million for Shared Labs program
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
First Tissue Bank May Help Solve Mystery of Long COVID Misery
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
Fred Hutch to lead new federal Cancer Screening Research Network
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
CPRIT approved almost $100 million in grants to advance the fight against cancer in Texas
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
Biotechnology | Disease | FDA | Therapeutics
FDA approved Xolair as first and only medicine for children and adults with one or more food allergies
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
FDA approved first medication to treat severe frostbite
On Feb. 14, 2024, the U.S. Food and Drug Administration (FDA) approved Eicos Sciences’ Aurlumyn (iloprost) injection to…
European Commission approved first CRISPR/Cas9 gene-edited therapy, CASGEVY for reatment of SCD and TDT
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
Alaska Department of Health confirmed first fatal case of Alaskapox virus
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
Deschutes County confirmed case of human plague in local resident
On Feb. 8, 2024, Deschutes County Health Services in Bend, Oregon confirmed a case of human plague in…
China builds world’s most detailed human genome with ‘enormous’ implications for disease treatment
On Feb. 2, 2024, Chinese scientists announced they have assembled the world’s most detailed human genome yet, a…
Gene study identifies DNA variants linked to dyslexia
On Jan. 25, 2024, a study led by the University of Edinburgh, is the largest genetic study of…
Biotechnology | COVID-19 | Diagnostics | Disease | Neurology | Therapeutics
Washington University’s Jeffrey T. Fort Neuroscience Research building dedicated
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…